
|Articles|November 1, 2002
Government warns drug makers to maintain compliance
OIG document sayssome drug marketing practices may violate anti-kickback statute
Advertisement
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Related Content
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves label changes for first batch of menopausal hormone therapy products
2
Urologist explains science behind HA penile injections
3
Dual AR blockade shows promise for treatment-naïve mHSPC
4
Pearls & Perspectives: Expanding Options in Male Incontinence, with Laura Horodyski, MD
5





